⌘K

Login Start Free

Home/Filings/4/0001387131-20-004497

4//SEC Filing

Rhodes John B 4

Accession 0001387131-20-004497

CIK 0001430306other

View on SEC.gov Company Profile

Filed

May 5, 8:00 PM ET

Accepted

May 6, 6:38 PM ET

Size

5.4 KB

Accession

0001387131-20-004497

Insider Transaction Report

Form 4

Period: 2020-05-04

Tonix Pharmaceuticals Holding Corp.TNXP

Director

Transactions

Award
Stock Option
2020-05-04+75,000→ 75,000 total
Exercise: $0.77From: 2021-05-04Exp: 2030-05-04→ Common Stock (75,000 underlying)

Footnotes (1)

[F1]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.

Documents

1 file

4
ownership.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Tonix Pharmaceuticals Holding Corp.

CIK 0001430306

Entity typeother

Related Parties

1

filerCIK 0001346251

Filing Metadata

Form type: 4
Filed: May 5, 8:00 PM ET
Accepted: May 6, 6:38 PM ET
Size: 5.4 KB

View on SEC.gov